These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 37683695)
1. Use of recombinant S1 protein with hFc for analysis of SARS-CoV-2 adsorption and evaluation of drugs that inhibit entry into VERO E6 cells. Couto JCM; Vidal T; Decker ER; Santurio JM; Mello CF; Pillat MM Immunol Lett; 2023 Nov; 263():105-112. PubMed ID: 37683695 [TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions. Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP mBio; 2021 Mar; 12(2):. PubMed ID: 33785634 [TBL] [Abstract][Full Text] [Related]
3. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells. Caohuy H; Eidelman O; Chen T; Liu S; Yang Q; Bera A; Walton NI; Wang TT; Pollard HB Sci Rep; 2021 Nov; 11(1):22195. PubMed ID: 34773067 [TBL] [Abstract][Full Text] [Related]
5. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses. Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility to recombinant SARS-CoV-2 spike protein entry in the lungs of high-fat diet-induced obese mice. Gotoh K; Satoh F; Uesugi H; Noguchi T; Matsuda N; Sada K; Miyamoto S; Ozeki Y; Yoshida Y; Okamoto M; Masaki T; Kawabe T; Shibata H FASEB J; 2024 May; 38(10):e23656. PubMed ID: 38752523 [TBL] [Abstract][Full Text] [Related]
8. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA Elife; 2021 Aug; 10():. PubMed ID: 34435953 [TBL] [Abstract][Full Text] [Related]
9. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2. Jafary F; Jafari S; Ganjalikhany MR Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306 [TBL] [Abstract][Full Text] [Related]
10. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding. Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction. Eka Saputri M; Aisyah Rahmalia Effendi S; Nadila R; Azzam Fajar S; Damajanti Soejoedono R; Handharyani E; Nadia Poetri O Int Immunopharmacol; 2022 Nov; 112():109280. PubMed ID: 36183680 [TBL] [Abstract][Full Text] [Related]
12. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection. Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS J Biol Chem; 2021; 296():100759. PubMed ID: 33965375 [TBL] [Abstract][Full Text] [Related]
13. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin. Partridge LJ; Urwin L; Nicklin MJH; James DC; Green LR; Monk PN Cells; 2021 Jun; 10(6):. PubMed ID: 34200372 [TBL] [Abstract][Full Text] [Related]
14. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling. Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526 [TBL] [Abstract][Full Text] [Related]
15. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2. Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling. Karthika T; Joseph J; Das VRA; Nair N; Charulekha P; Roji MD; Raj VS Cells; 2021 Jul; 10(7):. PubMed ID: 34359983 [TBL] [Abstract][Full Text] [Related]
17. Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction. Kim YS; Kwon EB; Kim B; Chung HS; Choi G; Kim YH; Choi JG Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293371 [TBL] [Abstract][Full Text] [Related]
18. Mechanical activation of spike fosters SARS-CoV-2 viral infection. Hu W; Zhang Y; Fei P; Zhang T; Yao D; Gao Y; Liu J; Chen H; Lu Q; Mudianto T; Zhang X; Xiao C; Ye Y; Sun Q; Zhang J; Xie Q; Wang PH; Wang J; Li Z; Lou J; Chen W Cell Res; 2021 Oct; 31(10):1047-1060. PubMed ID: 34465913 [TBL] [Abstract][Full Text] [Related]
19. The Effects of Aβ Hsu JT; Tien CF; Yu GY; Shen S; Lee YH; Hsu PC; Wang Y; Chao PK; Tsay HJ; Shie FS Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360989 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of ACE2-Spike Interaction by an ACE2 Binder Suppresses SARS-CoV-2 Entry. Shin YH; Jeong K; Lee J; Lee HJ; Yim J; Kim J; Kim S; Park SB Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202115695. PubMed ID: 35043545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]